target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id CNGA2,395,Q16280,Human,dequalinium,2313,,2993,Nc1cc(C)[n+](c2c1cccc2)CCCCCCCCCC[n+]1c(C)cc(c2c1cccc2)N,"InChI=1S/C30H38N4/c1-23-21-27(31)25-15-9-11-17-29(25)33(23)19-13-7-5-3-4-6-8-14-20-34-24(2)22-28(32)26-16-10-12-18-30(26)34/h9-12,15-18,21-22,31-32H,3-8,13-14,19-20H2,1-2H3/p+2",PCSWXVJAIHCTMO-UHFFFAOYSA-P,Channel blocker,Antagonist,,,,,pIC50,,5.6,,,,,,=,,,,14981138, CNGA2,395,Q00195,Rat,cyclic GMP,2347,,135398570,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O,"InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1",ZOOGRGPOEVQQDX-UUOKFMHZSA-N,Activator,Agonist,,yes,,,pEC50,5.76,,5.6,EC50,2500.0,,1740.0,=,,,,7522482|7522325|22786723, CNGA2,395,Q00195,Rat,L-(cis)-diltiazem,2349,,198107,COc1ccc(cc1)[C@H]1Sc2ccccc2N(C(=O)[C@H]1OC(=O)C)CCN(C)C,"InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m0/s1",HSUGRBWQSSZJOP-LEWJYISDSA-N,Channel blocker,Antagonist,,,,,pKi,,2.12,,,,,,,,,,1697649, CNGA2,395,Q00195,Rat,all-trans-retinal,2350,,638015,O=C/C=C(/C=C/C=C(/C=C/C1=C(C)CCCC1(C)C)\C)\C,"InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+",NCYCYZXNIZJOKI-OVSJKPMPSA-N,Gating inhibitor,Antagonist,,,,,pIC50,,4.57,,,,,,,,,,12034887, CNGA2,395,Q00195,Rat,calmodulin,2351,Human,,,,,Gating inhibitor,Antagonist,,,,,pIC50,8.5,,7.7,,,,,,,,,7511217|7526466, CNGA2,395,Q00195,Rat,cyclic AMP,2352,,6076,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2N,"InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",IVOMOUWHDPKRLL-KQYNXXCUSA-N,Activator,Agonist,,yes,,,pEC50,4.34,,4.21,EC50,61600.0,,45700.0,=,,,,10377344|7522482|7522325|22786723, CNGA2,395,Q00195,Rat,PIP3,2353,,53477782,CC(=O)OC(OC(=O)C)COP(=O)(O[C@@H]1[C@H](O)[C@H](OP(=O)(O)O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O,"InChI=1S/C12H24O22P4/c1-4(13)29-6(30-5(2)14)3-28-38(26,27)34-9-7(15)10(31-35(17,18)19)12(33-37(23,24)25)11(8(9)16)32-36(20,21)22/h6-12,15-16H,3H2,1-2H3,(H,26,27)(H2,17,18,19)(H2,20,21,22)(H2,23,24,25)/t7-,8-,9-,10+,11-,12-/m0/s1",RQQIRMLGKSPXSE-UQPICLANSA-N,Gating inhibitor,Antagonist,,,,10,,,,,,,,,=,,,,17032767, CNGA2,395,Q00195,Rat,pseudechetoxin,2354,,,,,,Channel blocker,Antagonist,,,,,pKi,,8.3,,,,,,,,,,9892706|14638933,